Home › Funds › Informed Momentum Co LLC › KNSA
Informed Momentum Co LLC position in KNSA
KINIKSA PHARMACEUTICALS INTL · Health Care
Informed Momentum Co LLC reported holding 78,296 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 0.60% of its reported portfolio and ranking #39 among its reported holdings. Informed Momentum Co LLC has disclosed KNSA holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Informed Momentum Co LLC's KNSA position evolved
Informed Momentum Co LLC first disclosed a stake in KNSA in Q3 2023 at 124,438 shares (US$2.2M). The position peaked in Q3 2026 at 78,296 shares, worth US$5.8M. Across 7 filings, Informed Momentum Co LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 78,296 shares valued at US$5.8M — an increase of 22,531 shares quarter over quarter.. Notable position changes include a 41% trim in Q1 2026 (shares rose 33% over the following quarter), a 40% increase in Q3 2026 (shares rose 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 124.44K | $2.16M | New |
| Q2 2025 | 105.75K | $2.93M | New |
| Q3 2025 | 97.94K | $3.74M | Reduce |
| Q4 2025 | 96.02K | $3.96M | Reduce |
| Q1 2026 | 56.49K | $2.72M | Reduce |
| Q2 2026 | 55.77K | $3.57M | Reduce |
| Q3 2026 | 78.30K | $5.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KNSA and 13F data
KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 50 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KNSA
- Rubric Capital Management LP 4.00M sh · $255.79M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M sh · $181.28M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.26M sh · $144.52M · Q2 2026
- Spruce Street Capital LP 918.07K sh · $68.50M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 466.05K sh · $34.77M · Q3 2026
- OBERWEIS ASSET MANAGEMENT INC/ 410.91K sh · $30.66M · Q3 2026
- ORBIMED ADVISORS LLC 420.60K sh · $26.90M · Q2 2026
- Penn Capital Management Company, LLC 347.66K sh · $25.97M · Q3 2026
- Soleus Capital Management, L.P. 246.35K sh · $15.75M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 202.02K sh · $15.07M · Q3 2026
- ArrowMark Colorado Holdings LLC 198.67K sh · $14.82M · Q3 2026
More on Informed Momentum Co LLC
FAQ
How long has Informed Momentum Co LLC held KNSA?
Informed Momentum Co LLC has disclosed KNSA holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is Informed Momentum Co LLC's current position in KNSA?
As of Q3 2026, Informed Momentum Co LLC holds 78.30K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $5.84M, representing 0.60% of its reported portfolio and ranking #39.
Has Informed Momentum Co LLC been buying or selling KNSA?
In the latest 13F filing (Q3 2026), Informed Momentum Co LLC increased its position in KNSA. The position peaked in Q3 2026 at 78.30K shares.
Which other funds hold KNSA?
Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.